In Steamboat Springs, Colorado, February 8 – 12, the American Academy of Orthopaedic Surgeons (AAOS) /American Orthopaedic Society for Sports Medicine (AOSSM) will be offering their 18th annual sports medicine course with a focus on biologics, contemporary surgical techniques, and diagnostic and therapeutic ultrasound training.
Biologics Highlight 18th Annual AAOS/AOSSM Course
1 min read Premium comments
Secondary
The course will include updates on biologics, the most recent rehabilitation and return to sport guidelines, the on and off-the field management of the athlete, sports nutrition, psychology as well as a half-day ultrasound course with live laboratory, not to mention live patient presentations and panel decision-making.
Brian J. Cole, M.D, MBA, course director and orthopedic surgeon at Midwest Orthopaedics at Rush University Medical Center in Chicago, Illinois, told OTW that “case-based learning, faculty interaction, the inclusion of biologics, nutrition and rehabilitation in addition to a focus on the most contemporary solutions to manage sport-related injury remain a unique offering for this special course.”
Also on the agenda is a spotlight session on “Applied Biologics: Amniotic Tissue: Science, Indications and Reimbursement” and a discussion on the technique of articular cartilage repair moderated by Adam B. Yanke, M.D., a sports medicine orthopedic surgeon with Midwest Orthopaedics at Rush University Medical Center.
More details about the 18th Annual AAOS/AOSSM sports medicine course can be found here.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.